Potent Neutralizing Antibody Against Zika Virus in Rhesus Macaques
Author Information
Author(s): Nkolola Joseph P., Hope David, Guan Ruoran, Colarusso Alessandro, Aid Malika, Weiss Deborah, Misamore John, Andersen Hanne, Lewis Mark G., Williamson Lauren, Carnahan Robert H., Crowe James E. Jr., Barouch Dan H.
Primary Institution: Beth Israel Deaconess Medical Center
Hypothesis
Can the engineered monoclonal antibody ZIKV-117-LALA-YTE provide protection against Zika virus in rhesus macaques?
Conclusion
The study demonstrates that ZIKV-117-LALA-YTE provides complete protection against Zika virus in rhesus macaques at a low dose.
Supporting Evidence
- ZIKV-117-LALA-YTE showed complete protection at a dose of 0.016 mg/kg.
- Median serum concentrations of 0.13 µg/mL were associated with full protection.
- Animals receiving higher doses exhibited no detectable viremia after Zika virus challenge.
Takeaway
Scientists tested a special antibody to see if it could protect monkeys from the Zika virus, and it worked really well!
Methodology
Twenty-four rhesus macaques were infused with varying doses of ZIKV-117-LALA-YTE and then challenged with Zika virus to assess protection.
Potential Biases
Potential conflicts of interest due to funding sources and author affiliations.
Limitations
The study was conducted in a controlled environment with a specific animal model, which may not fully represent human responses.
Participant Demographics
24 rhesus macaques, 12 male and 12 female, ages 5–14 years.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website